Research & Development



  “不用,你坐在這等著吃就好。”林徵羽將遙控器放進陸昔年手里,“無聊的話就看會電視,我很快弄好。”   陸昔年抬頭望向他,大大眼里滿是疑惑。亚洲情色   陸昔年頗為得意的晃晃腦袋︰“哈哈, 誰叫你這麼好騙。”色情偷拍欧美日韩亚洲   或者說是王淼淼單方面針對高思明。   “那後面這幾次中獎是怎麼回事?該不會都是黑幕吧?”亚洲色色   那時候何修還沒退役,他的微博除了一些日常之外,剩下的全是關于scl的周邊消息,比賽贏了抽獎哈哈哈,比賽輸了就抽獎祈福,還瘋狂轉發各種何修神操作的視頻。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo